Market Overview:
The global anti-microbial/anti-fungal tests market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of microbial infections, antifungal resistance, and antimicrobial resistance. In addition, the growing demand for rapid diagnostic tests is also contributing to the growth of this market. The global anti-microbial/anti-fungal tests market is segmented on the basis of type, application, and region. On the basis of type, this market is segmented into microbial infection testing, antifungal resistance testing, antimicrobial resistance testing, and fungal infection testing. The microbial infection testing segment accounted for the largest share of this market in 2017 owing to rising incidence rates of various types of infections caused by microorganisms such as bacteria and viruses worldwide. On the basis of application, this market is divided into hospitals & clinics; ambulatory surgical centers; community health centers; reference laboratories; and other applications (home care settings & long term care facilities).
Product Definition:
Anti-microbial/anti-fungal tests are used to determine if a substance or organism is effective against microorganisms such as bacteria, fungi, and viruses. The tests are important for developing new antibiotics and other medications to treat infections, as well as for identifying the most effective strains of microorganisms for use in biotechnology applications.
Microbial Infection:
Microbial infection is the presence of harmful bacteria, viruses or fungi in a patient's body. Microbial infections are amongst the most common infectious diseases and can affect any part of the human body. The microbial infection market includes various products such as antibiotics, antiseptics/antimicrobial agents, vaccines and diagnostic agents which are used to treat microbial infections.
Antifungal Resistance:
Antifungal resistance is the ability of a microorganism to grow and multiply despite the presence of an antifungal drug. It is mainly observed in bacteria and fungi, but can also be found in some viruses. The most common type of antifungal resistance that occurs due to misuse or overuse of anti-fungal drugs is called pharmacological or chemical resistance.
Application Insights:
Based on application, the market is segmented into hospitals, ambulatory surgical centers, clinics and community health centers, reference laboratories. The clinics and health centers accounted for the largest share in 2017 due to increasing awareness about preventive healthcare along with rising incidences of infectious diseases that are transmitted through contact with contaminated surfaces or via respiratory droplets.
The hospitals segment is anticipated to witness lucrative growth over the forecast period due to an increase in hospital-acquired infections that lead to longer hospital stays and higher medical costs. According to a study published by NCBI in 2018, it was estimated that around 60% of total infections occur within 1 days of discharge from a patient¢â‚¬â„¢s room which increases expenditure on healthcare as well as spreads infection further leading to increased mortality & morbidity rates among patients hospitalized for various conditions such as pneumonia or urinary tract infections.
Regional Analysis:
North America dominated the global market in 2017. The presence of sophisticated healthcare infrastructure, high awareness levels pertaining to the prevention and treatment of infectious diseases, and increasing prevalence of targeted infections are some factors attributing to its large share.
Asia Pacific is expected to be the fastest-growing region over the forecast period owing to rising incidences of fungal & bacterial infections as well as antimicrobial resistance in emerging countries such as India and China. In addition, a rise in international travel is also anticipated to boost market growth during this period. Moreover, supportive government initiatives for building diagnostic laboratories; along with growing investments by key players for expanding their geographical reach are some factors that can be attributed for rapid growth within this region.
Growth Factors:
- Increasing incidence of infectious diseases: The increasing incidence of infectious diseases is one of the key growth drivers for the anti-microbial/anti-fungal tests market. This is because there has been a rise in the number of people who are susceptible to such infections and also, there has been an increase in the number of outbreaks due to various pathogens.
- Growing awareness about preventive measures: There is a growing awareness among people about preventive measures against infectious diseases, which is driving demand for anti-microbial/anti-fungal tests. This includes both personal hygiene measures as well as vaccination programmes.
- Technological advancements: The technological advancements in diagnostic testing are aiding growth prospects for the global anti-microbial/anti-fungal tests market. For instance, new molecular techniques are being developed that can detect even low levels of microorganisms and this is helping to improve accuracy and speed up diagnosis process times significantly. Additionally, development of novel drugs that can treat resistant strains is also aiding market growth prospects positively .
Scope Of The Report
Report Attributes
Report Details
Report Title
Anti-microbial/Anti-fungal Tests Market Research Report
By Type
Microbial Infection, Antifungal Resistance, Antimicrobial Resistance, Fungal Infection
By Application
Hospitals, Ambulatory Surgical Centers, Clinics, Community Health Centers, Reference Laboratories
By Companies
Abbott, bioMerieux, Bio-Rad, Bruker, Danaher, Erba Mannheim, F. Hoffmann-La Roche, Luminex, Meridian Bioscience, Norgen Biotek, Omega Diagnostics, Qiagen, Quidel, Thermo Fisher Scientific
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
212
Number of Tables & Figures
149
Customization Available
Yes, the report can be customized as per your need.
Global Anti-microbial/Anti-fungal Tests Market Report Segments:
The global Anti-microbial/Anti-fungal Tests market is segmented on the basis of:
Types
Microbial Infection, Antifungal Resistance, Antimicrobial Resistance, Fungal Infection
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Ambulatory Surgical Centers, Clinics, Community Health Centers, Reference Laboratories
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- bioMerieux
- Bio-Rad
- Bruker
- Danaher
- Erba Mannheim
- F. Hoffmann-La Roche
- Luminex
- Meridian Bioscience
- Norgen Biotek
- Omega Diagnostics
- Qiagen
- Quidel
- Thermo Fisher Scientific
Highlights of The Anti-microbial/Anti-fungal Tests Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Microbial Infection
- Antifungal Resistance
- Antimicrobial Resistance
- Fungal Infection
- By Application:
- Hospitals
- Ambulatory Surgical Centers
- Clinics
- Community Health Centers
- Reference Laboratories
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Anti-microbial/Anti-fungal Tests Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Anti-microbial/anti-fungal tests are used to determine the presence of bacteria or fungi in a sample.
Some of the major companies in the anti-microbial/anti-fungal tests market are Abbott, bioMerieux, Bio-Rad, Bruker, Danaher, Erba Mannheim, F. Hoffmann-La Roche, Luminex, Meridian Bioscience, Norgen Biotek, Omega Diagnostics, Qiagen, Quidel, Thermo Fisher Scientific.
The anti-microbial/anti-fungal tests market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Anti-microbial/Anti-fungal Tests Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Anti-microbial/Anti-fungal Tests Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Anti-microbial/Anti-fungal Tests Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Anti-microbial/Anti-fungal Tests Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Anti-microbial/Anti-fungal Tests Market Size & Forecast, 2020-2028
4.5.1 Anti-microbial/Anti-fungal Tests Market Size and Y-o-Y Growth
4.5.2 Anti-microbial/Anti-fungal Tests Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Microbial Infection
5.2.2 Antifungal Resistance
5.2.3 Antimicrobial Resistance
5.2.4 Fungal Infection
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Ambulatory Surgical Centers
6.2.3 Clinics
6.2.4 Community Health Centers
6.2.5 Reference Laboratories
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Anti-microbial/Anti-fungal Tests Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Anti-microbial/Anti-fungal Tests Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Microbial Infection
9.6.2 Antifungal Resistance
9.6.3 Antimicrobial Resistance
9.6.4 Fungal Infection
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Ambulatory Surgical Centers
9.10.3 Clinics
9.10.4 Community Health Centers
9.10.5 Reference Laboratories
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Microbial Infection
10.6.2 Antifungal Resistance
10.6.3 Antimicrobial Resistance
10.6.4 Fungal Infection
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Ambulatory Surgical Centers
10.10.3 Clinics
10.10.4 Community Health Centers
10.10.5 Reference Laboratories
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Microbial Infection
11.6.2 Antifungal Resistance
11.6.3 Antimicrobial Resistance
11.6.4 Fungal Infection
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Ambulatory Surgical Centers
11.10.3 Clinics
11.10.4 Community Health Centers
11.10.5 Reference Laboratories
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Microbial Infection
12.6.2 Antifungal Resistance
12.6.3 Antimicrobial Resistance
12.6.4 Fungal Infection
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Ambulatory Surgical Centers
12.10.3 Clinics
12.10.4 Community Health Centers
12.10.5 Reference Laboratories
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Microbial Infection
13.6.2 Antifungal Resistance
13.6.3 Antimicrobial Resistance
13.6.4 Fungal Infection
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Ambulatory Surgical Centers
13.10.3 Clinics
13.10.4 Community Health Centers
13.10.5 Reference Laboratories
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Anti-microbial/Anti-fungal Tests Market: Competitive Dashboard
14.2 Global Anti-microbial/Anti-fungal Tests Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 bioMerieux
14.3.3 Bio-Rad
14.3.4 Bruker
14.3.5 Danaher
14.3.6 Erba Mannheim
14.3.7 F. Hoffmann-La Roche
14.3.8 Luminex
14.3.9 Meridian Bioscience
14.3.10 Norgen Biotek
14.3.11 Omega Diagnostics
14.3.12 Qiagen
14.3.13 Quidel
14.3.14 Thermo Fisher Scientific
